BIOSeedin Winter Innovation Partnering Summit @JPM Week

📍 San Francisco, CA
📅 January 11 , 2026

Redefining Licensing in the New Era
Join global leaders from pharma and biotech to shape the future of strategic partnerships.

Why Attend?
✅ In-depth China–US licensing discussions
✅ Live asset pitches from innovative biotech companies
✅ Exclusive networking with top decision-makers

Event Highlights

• Spotlight on China Asset Roadshows
  Over ten innovative Chinese biopharma companies in oncology, autoimmune, and metabolic diseases will showcase their latest R&D progress and partnering needs.

• Engagement with MNCs and Global Investors
  Executives from multinational pharma companies (MNCs) and leading international investment firms will join panel discussions and on-site exchanges, fostering cross-border collaboration.

• Efficient 1-on-1 Partnering System
  Dedicated meeting tables will be available for face-to-face discussions between participating companies, investors, and potential partners. A pre-scheduled partnering system ensures efficiency and productivity.

•  Focused Panel Discussions on Three Hot Areas
  The forum will host three focused panel discussions covering oncology, metabolic diseases, and autoimmune diseases, exploring R&D trends, partnership opportunities, and in-depth insights within each field.

Agenda

Panelists

Weiyong Sun, M.D., Ph.D.
Chief Business Officer, Hansoh Bio / Hansoh Pharma
Dr. Sun has over 25 years of experience in the pharmaceutical industry, including 20 years of proven success in global in- and out-licensing, deal structuring, and alliance management. He currently leads Global Business Development and Alliance Management at Hansoh Pharmaceutical Group, where his team has executed over 20 collaboration deals—including two ADC partnerships with GSK and a recent GLP-1 out-licensing agreement with Merck (MSD).
Prior to Hansoh, Dr. Sun spent 19 years at Daiichi Sankyo, contributing to both R&D and business development. He holds an M.D. from Peking University Medical School, a Ph.D. in Cell Biochemistry from the University of Tokyo, and an MBA from Columbia Business School.

Alexandria (Alex) Cogdill, M.Eng., Ph.D.
Head of Strategic Initiatives, Global Business Development, Daiichi Sankyo
Dr. Cogdill is a translational science and business development leader with 18 years of cross-sector experience across immunology, oncology, and advanced therapeutics. At Daiichi Sankyo, she drives global strategy bridging scientific innovation and commercial execution. With deep expertise in cell therapy, immuno-oncology, and platform partnerships, she has led high-value collaborations that connect breakthrough science with clinical and commercial impact.

Betty Huang
VP and Head of Collaborate to Cure Hub China, Bayer Pharmaceuticals
Betty leads Bayer’s Collaborate to Cure Hub in China, focusing on external innovation and strategic partnerships to accelerate transformative drug discovery. She plays a key role in connecting Bayer's global R&D with Asia's fast-growing biotech ecosystem, driving collaborations that advance next-generation therapies.

1-on-1 Partnering Sessions

• Morning: 9:30–11:30 (8 meeting tables, 30-minute slots)

• Afternoon: 14:00–16:30 (8 meeting tables, 30-minute slots)

Expected Participants

This event is expected to attract:

• BD & Licensing executives from multinational pharma companies (MNCs)

• Senior executives from overseas biotech companies

• Investors from leading international investment firms

• Founders and management of innovative Chinese biopharma companies

• Professionals from legal, consulting, and service organizations

Call for Roadshow Projects & Attendees

Roadshow Companies:
Innovative biopharma companies in oncology, autoimmune, or metabolic diseases with international collaboration potential.

Attendees:
International pharma companies, investors, industry experts, and professionals interested in connecting with Chinese innovative biopharma companies.

Limited spots available – register early!

How to Apply for Roadshow:
Submit a non-confidential business plan or company information to BP@bioSeedin.com

• Application Deadline: October 30, 2025

• Fee: $5,000
  *Seats for roadshows are limited; early application is recommended.

🎯 Limited to 200 senior executives
🎟️ Priority registration for JPM Week attendees

Secure your seat today and be part of the dealmaking action.

Accommodation
A limited number of rooms have been reserved at San Francisco Marriott Union Square, the official venue of the BIOSeedin Winter Innovation Partnering Summit.
We highly recommend attendees to book early to secure the special conference rate.

🏨 Hotel: San Francisco Marriott Union Square
📍 480 Sutter Street, San Francisco, CA 94108
💰 Special Rate: From USD 249 per night (subject to availability)
🔗 Reserve your room: https://surl.fan/kkc0pw

*Team Discount: Groups of 3 or more attendees are welcome to register together and enjoy an exclusive group rate. For details on team pricing, please contact yuhui.he@bioseedin.com